Evaluate the Efficacy and Safety of Oral Hydroxychloroquine, Indomethacin and Zithromax in Subjects With Mild Symptoms of COVID-19
Status unconfirmed · Phase 1/Phase 2
Conditions studied: COVID-19
In brief
Currently there are no US Food and Drug Administration (FDA)-approved drugs specifically for the treatment of patients with COVID-19. At present, clinical management includes infection prevention and control measures, as well as supportive care, including supplementary oxygen and mechanical ventilatory support when indicated. An array of drugs approved for other indications as well as several investigational drugs are being studied in several hundred clinical trials that are underway across the globe; however, currently there are no clinical trials available to patients in Arizona. This study will determine if a specific drug cocktail can improve clinical outcomes in patients with confirmed Mild SARS-CoV-2
Key facts
- Study ID
- NCT04344457
- Run by
- Perseverance Research Center, LLC
- People needed
- 80
- Starts
- 2020-04-16
- Expected to finish
- 2020-09-30
- Last updated by the study team
- 2020-07-01
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- > 18 years of age
- Willing and able to provide written informed consent prior to performing study procedures
- Confirmed Sars-CoV2 infection by PCR
- Have mild symptoms of Sars-CoV2
- Must show documentation of Sars-CoV2 to screening visit
- Must have had recent hematology and chemistry results
- Must be able to take heart rate daily
- Must agree to Skype/Facetime daily
- Must agree to take temperature daily
- Must agree not to enroll in another study of an investigational agent prior to completion of Day 14 of treatment.
You may not qualify if…
- Known to be allergic to research drugs or drug excipients
- Incapable of providing informed consent
- Participation in any other clinical trial of an experimental treatment for Sars-CoV2 infection
- Pregnancy, possible pregnancy or breast feeding
- Prolonged QT interval (>450)
- Moderate to severe symptoms of Sars-CoV2
- Renal failure
- Hepatic failure
- NSAID use
Where it is running
- Perseverance Research Center — Scottsdale, Arizona, United States (enrolling)
- Covidcraz 19, Llc — New Orleans, Louisiana, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.